Post-IPO Equity - NantKwest
Investment Firm
Overview
NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease.
Announced Date
Mar 26, 2019
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
NantKwest raised $39000000 on 2019-03-26 in Post-IPO Equity
NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 05, 2015 |  Post-IPO Equity - NantKwest | - | 17.0M | |
| Mar 26, 2019 | Post-IPO Equity - NantKwest | 1 | - | 39.0M |
| Dec 23, 2014 | Post-IPO Equity - NantKwest | - | 47.5M |
Recent Activity
There is no recent news or activity for this profile.